Ospemifene 60 mg

DRUG4 trials

Sponsors

Shionogi, Hospital Clinic of Barcelona

Conditions

AtrophyGenitourinary Syndrome of MenopauseSexual; Disorder, Arousal, FemaleVaginal DiseasesVulvovaginal Signs and Symptoms

Phase 3

A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

CompletedNCT00276094

ShionogiAtrophy, Vaginal Diseases

Start: 2006-01-31End: 2007-12-31Updated: 2013-06-28

A Clinical Study to Evaluate the Safety of Ospemifene

CompletedNCT00566982

ShionogiAtrophy, Vaginal Diseases

Start: 2007-10-31End: 2009-07-31Updated: 2018-05-18

Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity

CompletedNCT00729469

ShionogiAtrophy, Vaginal Diseases

Start: 2008-07-31End: 2009-08-31Updated: 2018-05-18

Phase 4

Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders

CompletedNCT04677491

Hospital Clinic of BarcelonaGenitourinary Syndrome of Menopause, Sexual; Disorder, Arousal, Female, Vulvovaginal Signs and Symptoms

Start: 2021-11-01End: 2023-12-01Updated: 2025-09-15